Association Between the Number of Certified Buprenorphine Prescribers and the Quantity of Buprenorphine Prescriptions: Evidence from 2015 to 2017.
作者信息
Lin Lee-Kai, Simon Kosali, Hollingsworth Alex, Saloner Brendan
机构信息
Department of Economics, Tunghai University, Taichung, Taiwan.
O'Neill School of Public and Environmental Affairs, Indiana University, Bloomington, IN, USA.
出版信息
J Gen Intern Med. 2019 Nov;34(11):2313-2315. doi: 10.1007/s11606-019-05165-6.
Abstract
摘要
相似文献
1
Association Between the Number of Certified Buprenorphine Prescribers and the Quantity of Buprenorphine Prescriptions: Evidence from 2015 to 2017.
J Gen Intern Med. 2019 Nov;34(11):2313-2315. doi: 10.1007/s11606-019-05165-6.
2
Trends in Buprenorphine Use in US Jails and Prisons From 2016 to 2021.
JAMA Netw Open. 2021 Dec 1;4(12):e2138807. doi: 10.1001/jamanetworkopen.2021.38807.
3
Rethinking Opioid Dose Tapering, Prescription Opioid Dependence, and Indications for Buprenorphine.
Ann Intern Med. 2019 Sep 17;171(6):427-429. doi: 10.7326/M19-1488. Epub 2019 Aug 27.
4
Growing importance of high-volume buprenorphine prescribers in OUD treatment: 2009-2018.
Drug Alcohol Depend. 2024 Jun 1;259:111290. doi: 10.1016/j.drugalcdep.2024.111290. Epub 2024 Apr 16.
5
Rise and regional disparities in buprenorphine utilization in the United States.
Pharmacoepidemiol Drug Saf. 2020 Jun;29(6):708-715. doi: 10.1002/pds.4984. Epub 2020 Mar 16.
6
Association of Buprenorphine-Waivered Physician Supply With Buprenorphine Treatment Use and Prescription Opioid Use in Medicaid Enrollees.
JAMA Netw Open. 2018 Sep 7;1(5):e182943. doi: 10.1001/jamanetworkopen.2018.2943.
7
Patterns of physician prescribing for opioid maintenance treatment in Ontario, Canada in 2014.
Drug Alcohol Depend. 2017 Aug 1;177:315-321. doi: 10.1016/j.drugalcdep.2017.05.002. Epub 2017 Jul 19.
8
Monthly Patient Volumes of Buprenorphine-Waivered Clinicians in the US.
JAMA Netw Open. 2020 Aug 3;3(8):e2014045. doi: 10.1001/jamanetworkopen.2020.14045.
9
Barriers Rural Physicians Face Prescribing Buprenorphine for Opioid Use Disorder.
Ann Fam Med. 2017 Jul;15(4):359-362. doi: 10.1370/afm.2099.
10
Use and misuse of opioid agonists in opioid addiction.
Cleve Clin J Med. 2017 May;84(5):377-384. doi: 10.3949/ccjm.84a.16091.
引用本文的文献
1
Racial/ethnic disparities in timely receipt of buprenorphine among Medicare disability beneficiaries.
Drug Alcohol Depend. 2023 Nov 1;252:110963. doi: 10.1016/j.drugalcdep.2023.110963. Epub 2023 Sep 14.
2
Impact of COVID-19 pandemic on chronic pain and opioid use in marginalized populations: A scoping review.
Front Public Health. 2023 Apr 17;11:1046683. doi: 10.3389/fpubh.2023.1046683. eCollection 2023.
3
Implications of county-level variation in U.S. opioid distribution.
Drug Alcohol Depend. 2021 Feb 1;219:108501. doi: 10.1016/j.drugalcdep.2020.108501. Epub 2021 Jan 3.
4
Association Between Medicaid Expansion and Rates of Opioid-Related Hospital Use.
JAMA Intern Med. 2020 May 1;180(5):753-759. doi: 10.1001/jamainternmed.2020.0473.
本文引用的文献
1
Association of Buprenorphine-Waivered Physician Supply With Buprenorphine Treatment Use and Prescription Opioid Use in Medicaid Enrollees.
JAMA Netw Open. 2018 Sep 7;1(5):e182943. doi: 10.1001/jamanetworkopen.2018.2943.
2
Changes in Buprenorphine-Naloxone and Opioid Pain Reliever Prescriptions After the Affordable Care Act Medicaid Expansion.
JAMA Netw Open. 2018 Aug 3;1(4):e181588. doi: 10.1001/jamanetworkopen.2018.1588.
3
Characteristics and prescribing practices of clinicians recently waivered to prescribe buprenorphine for the treatment of opioid use disorder.
Addiction. 2019 Mar;114(3):471-482. doi: 10.1111/add.14436. Epub 2018 Oct 15.
4
Federal Response to the Opioid Crisis.
Curr HIV/AIDS Rep. 2018 Aug;15(4):293-301. doi: 10.1007/s11904-018-0398-8.
5
Patterns of Buprenorphine-Naloxone Treatment for Opioid Use Disorder in a Multistate Population.
Med Care. 2017 Jul;55(7):669-676. doi: 10.1097/MLR.0000000000000727.
Zotero 插件